Density of tumor-associated macrophages correlates with lymph node metastasis in papillary thyroid carcinoma
- PMID: 22870901
- PMCID: PMC3429273
- DOI: 10.1089/thy.2011.0452
Density of tumor-associated macrophages correlates with lymph node metastasis in papillary thyroid carcinoma
Abstract
Background: Tumor-associated macrophages (TAMs) have recently been recognized as being important players in the tumoriogenesis of many cancers, including advanced thyroid cancer. However, a role in papillary thyroid carcinoma (PTC), the most prevalent thyroid cancer, has not been established. We hypothesized that TAMs also facilitate tumor progression in PTC.
Methods: We investigated TAMs density in both benign thyroid lesions and PTC tumors by CD68 immunostaining. CD68-positive cell density was further associated with the clinicopathological characteristics of PTC patients. Finally, TAMs were isolated from PTC tumors and phenotyped by cytokine and receptor profiling.
Results: The overall density of TAMs was found to be significantly higher in PTC tumors, compared with thyroid goiter and follicular adenoma. The density of TAMs was positively associated with lymph node metastasis in TNM (tumor-node-metastasis) stages III/VI compared with stages I/II. No association was observed in other common tumor features, including the BRAF mutation. The isolated TAMs presented with high levels of M2-associated cytokine and receptors, making M2 the predominant TAM phenotype.
Conclusions: TAMs may play a functional role in the progression of PTC.
Figures
References
-
- Davies L. Welch HG. Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA. 2006;295:2164–2167. - PubMed
-
- Elisei R. Molinaro E. Agate L. Bottici V. Masserini L. Ceccarelli C. Lippi F. Grasso L. Basolo F. Bevilacqua G. Miccoli P. Di Coscio G. Vitti P. Pacini F. Pinchera A. Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question. J Clin Endocrinol Metab. 2010;95:1516–1527. - PubMed
-
- Mazzaferri EL. Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med. 1994;97:418–428. - PubMed
-
- DeGroot LJ. Kaplan EL. McCormick M. Straus FH. Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab. 1990;71:414–424. - PubMed
-
- Mazzaferri EL. Kloos RT. Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab. 2001;86:1447–1463. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
